Condition
Curarization, Postoperative Residual
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (2)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07477132Phase 4Not Yet RecruitingPrimary
A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months Old
NCT03519633Phase 2CompletedPrimary
Role of Curarization During Anesthesia for Laparoscopic Hysterectomy
NCT04762420Completed
Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring
NCT03585400Completed
Validation of the REPS Prediction Tool
NCT03519724Phase 2UnknownPrimary
Role of Curarization During Anesthesia for Gynecologic Surgical Laparotomy Procedures
Showing all 5 trials